Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
1,729
Views
2
CrossRef citations to date
0
Altmetric
Cardiovascular
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin
Dejan Milentijevica Janssen Scientific Affairs, LLC, Titusville, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0003-2159-0049
Jennifer H. Lina Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Yen-Wen Chena Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Emily Koganb Janssen Research & Development, LLC, Raritan, NJ, USA
https://orcid.org/0000-0003-1364-6743
Shubham Shrivastavac Mu Sigma Business Solutions Pvt. Ltd, Bengaluru, India
, Erik Sjoelandb Janssen Research & Development, LLC, Raritan, NJ, USA
& Mark Albertsd Hartford HealthCare, Hartford, CT, USA
https://orcid.org/0000-0001-5488-6810
Pages 212-217
|
Received 20 Aug 2020, Accepted 05 Jan 2021, Published online: 13 Feb 2021
Related Research Data
Healthcare costs before and after stroke in non-valvular atrial fibrillation patients who initiated treatment with rivaroxaban or warfarin
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.